FDMT
Closed
4d Molecular Therapeutics inc
4.15
+0.44 (+11.86%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 3.71
Day's Range: 3.68 - 4.19
Send
sign up or login to leave a comment!
When Written:
17.29
4D Molecular Therapeutics Inc. is a biotechnology company that develops gene therapies for treating genetic diseases. The company's proprietary platform uses adeno-associated virus (AAV) vectors to deliver therapeutic genes to targeted cells in the body. This approach allows for more precise and efficient delivery of gene therapies, potentially reducing side effects and improving patient outcomes. 4D Molecular Therapeutics has several pipeline programs in preclinical and clinical development for a range of genetic diseases, including cystic fibrosis, Fabry disease, and Duchenne muscular dystrophy. The company was founded in 2013 and is headquartered in Emeryville, California.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








